Startseite Medizin Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays

  • Evelyn Stelzl , Carola van der Meer , Remko Gouw , Marcel Beld , Maja Grahovac , Egon Marth und Harald H. Kessler
Veröffentlicht/Copyright: 1. Februar 2007
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 45 Heft 2

Abstract

Background: Hepatitis C virus (HCV) genotyping and accurate subtyping is becoming increasingly relevant to epidemiological studies, clinical management, pathogenicity, and vaccine development.

Methods: The TRUGENE® HCV 5′NC Genotyping Kit, the new VERSANT® HCV Genotype 2.0 Assay (LiPA), and a new laboratory-developed HCV NS5b sequencing assay designed for automated sequencing of the HCV NS5b region were used. Clinical samples and a molecular diagnostics HCV genotyping proficiency program panel were used to determine accuracy and differentiate performance characteristics of the three methods.

Results: All amplified samples from among the members of a HCV genotyping proficiency program panel that contained a single HCV genotype were subtyped correctly using all three HCV genotyping assays. With the TRUGENE® HCV 5′NC Genotyping Kit, the HCV subtype was determined in 357 of 441 of routine clinical samples. When the 84 samples with only genotype results were retested with the VERSANT® HCV Genotype 2.0 Assay (LiPA), 61 could be further subtyped accurately. With the new laboratory-developed HCV NS5b sequencing assay, all 84 could be subtyped accurately.

Conclusions: The two new methods show advantages over the routinely used TRUGENE® HCV 5′NC Genotyping Kit in terms of genotyping and subtyping accuracy by utilizing part of the HCV core region and NS5b region, respectively.

Clin Chem Lab Med 2007;45:167–70.

:

Corresponding author: Harald H. Kessler, Molecular Diagnostics Laboratory, Institute of Hygiene, Universitaetsplatz 4, 8010 Graz, Austria Phone: +43-316-3804363, Fax: +43-316-3809649,

References

1. Simmonds P. Viral heterogeneity of the hepatitis C virus. J Hepatol1999;1:54–60.10.1016/S0168-8278(99)80375-4Suche in Google Scholar

2. Smith DB, McAllister J, Casino C, Simmonds P. Virus “quasispecies”: making a mountain out of a molehill? J Gen Virol1997;78:1511–9.10.1099/0022-1317-78-7-1511Suche in Google Scholar

3. Nakano T, Lu L, Liu P, Pybus OG. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis2004;190:1098–108.10.1086/422606Suche in Google Scholar

4. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, et al. European and Italian Seroconverter Studies. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis2004;189:292–302.10.1086/380821Suche in Google Scholar

5. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res2003;59:1–11.10.1016/S0166-3542(03)00088-3Suche in Google Scholar

6. Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med2004;140:370–81.10.7326/0003-4819-140-5-200403020-00033Suche in Google Scholar PubMed

7. Hofmann WP, Zeuzem S, Sarrazin C. Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. J Clin Virol2005;32:86–91.10.1016/j.jcv.2004.08.004Suche in Google Scholar PubMed

8. Mazzeo C, Azzaroli F, Giovanelli S, Dormi A, Festi D, Colecchia A, et al. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut2003;52:1030–4.10.1136/gut.52.7.1030Suche in Google Scholar PubMed PubMed Central

9. Resti M, Jara P, Hierro L, Azzari C, Giacchino R, Zuin G, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol2003;70:373–7.10.1002/jmv.10405Suche in Google Scholar PubMed

10. Nolte FS, Green AM, Fiebelkorn KR, Caliendo AM, Sturchio C, Grunwald A, et al. Clinical evaluation of two methods for genotyping hepatitis C virus based upon analysis of the 5′ non coding region. J Clin Microbiol2003;41:1558–64.10.1128/JCM.41.4.1558-1564.2003Suche in Google Scholar PubMed PubMed Central

11. Hoofnagle JH. Management of hepatitis C: current and future perspectives. J Hepatol1999;31(Suppl 1):264–8.10.1016/S0168-8278(99)80414-0Suche in Google Scholar

12. Migliaccio G, Tomassini JE, Carroll SS, Tomei L, Altamura S, Bhat B, et al. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatic C virus replication in vitro. J Biol Chem2003;278:49164–70.10.1074/jbc.M305041200Suche in Google Scholar

13. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Ga-schen B, et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol1998;143:2493–503.10.1007/s007050050479Suche in Google Scholar

14. Simmonds P, Bukh J, Combet C, Deleage G, Nobuyuki E, Feinstone PH, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology2005;42:962–73.10.1002/hep.20819Suche in Google Scholar

15. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol1994;75:1053–61.10.1099/0022-1317-75-5-1053Suche in Google Scholar

16. Simmonds P. Genetic diversity and evolution of hepatitis C virus – 15 years on. J Gen Virol2004;85:3173–88.10.1099/vir.0.80401-0Suche in Google Scholar

17. Germer JJ, Rys PN, Thorvilson JN, Persing DH. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol1999;37:2625–30.10.1128/JCM.37.8.2625-2630.1999Suche in Google Scholar

18. Chen Z, Weck KE. Hepatitis C virus genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol2002;40:3127–37.10.1128/JCM.40.9.3127-3134.2002Suche in Google Scholar

19. Andersson JC, Simonetti J, Fisher DG, Williams J, Yamamura Y, Rodriguez N, et al. Comparison of different HCV viral load and genotyping assays. J Clin Virol2003;28:27–37.10.1016/S1386-6532(02)00235-4Suche in Google Scholar

20. Haushofer AC, Berg J, Hauer R, Trubert-Exinger D, Stekel HG, Kessler HH. Genotyping of hepatitis C virus – comparison of three assays. J Clin Virol2003;27:276–85.10.1016/S1386-6532(02)00183-XSuche in Google Scholar

21. Beld M, Gouw R, van der Meer C, Elkin C, Leung K, Guettouche T, et al. Hepatitis C virus (HCV) genotype and subtype determination using a new NS5b sequencing tool. Hepatology2005;42(Suppl 1):443A–4A.Suche in Google Scholar

Published Online: 2007-02-01
Published in Print: 2007-02-01

©2007 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
  2. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
  3. Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
  4. Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
  5. Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
  6. Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
  7. Patient hydration: a major source of laboratory uncertainty
  8. Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
  9. Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
  10. HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
  11. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
  12. Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
  13. Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
  14. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
  15. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
  16. Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
  17. Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
  18. Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
  19. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
  20. Plasma homocysteine cutoff values for venous thrombosis
  21. Lipid transfer protein activities in subjects with impaired glucose tolerance
  22. Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
  23. Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
  24. The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
  25. Standardization of ischemia-modified albumin testing: adjustment for serum albumin
  26. Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
  27. To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
  28. To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
  29. Accreditation of medical laboratories in the European Union
  30. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Heruntergeladen am 30.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.043/html?lang=de
Button zum nach oben scrollen